Back to results
CompletedPhase 3

Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction

NCT07146360

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Regional State Budgetary Healthcare Institution "Altai Regional Cardiological Dispensary"

Barnaul, Altayskiy Kray, Russia

+21 additional locations

View on ClinicalTrials.gov
Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction — TrialFind